Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $46.4000 (-7.21%) ($46.3000 - $46.4000) on Wed. Jan. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.27% (three month average) | RSI | 33 | Latest Price | $46.4000(-7.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.6% a day on average for past five trading days. | Weekly Trend | TGTX declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(63%) ARKK(59%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -3.135% in a week (0% probabilities). VIXM(-41%) VXX(-36%) UUP(-19%) UNG(-3%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.135% (StdDev 6.27%) | Hourly BBV | -2.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $41.89(-9.72%) | Inflection Point | Yes | Resistance Level | $50.91 | 5 Day Moving Average | $48.69(-4.7%) | 10 Day Moving Average | $49.68(-6.6%) | 20 Day Moving Average | $50.91(-8.86%) | To recent high | -15.2% | To recent low | 84% | Market Cap | $5.877b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |